drugset / Trial / NCT00699712

Study to Assess Hemodynamic Effects, Safety and Tolerability of Chimeric Natriuretic Peptide (CD-NP) in Patients With Stabilized Acute Heart Failure (AHF)

NCT00699712 ↗

NaSingle-groupOpen-labelTreatment

Summary

To access the efficacy of intravenous (IV) administration of CD-NP on changes in cardiac output and wedge pressure in patients with stabilized acute heart failure

Timeline

Start
2008-06
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Chimeric natriuretic peptide Unknown — Intravenous

Indications